Given the pervasiveness of alcohol use disorders (AUDs) in the United States, Dr. Mark Willenbring says, “we need to be intervening at a much earlier stage and providing treatment to a much broader range of people then we currently do.” Dr. Willenbring, director of the National Institute on Alcohol Abuse and Alcoholism's Division of Treatment and Recovery Research, joins host Dr. Larry Kaskel to talk about new information from epidemiologic research on the prevalence and progression of heavy drinking and alcohol use disorders. In addition, Dr. Willenbring discusses the subtypes of alcohol dependence, and the nature of AUDs, in the context of DSM revisions.
Alcohol Use Disorders: Can We Do More?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Given the pervasiveness of alcohol use disorders (AUDs) in the United States, Dr. Mark Willenbring says, “we need to be intervening at a much earlier stage and providing treatment to a much broader range of people then we currently do.” Dr. Willenbring, director of the National Institute on Alcohol Abuse and Alcoholism's Division of Treatment and Recovery Research, joins host Dr. Larry Kaskel to talk about new information from epidemiologic research on the prevalence and progression of heavy drinking and alcohol use disorders. In addition, Dr. Willenbring discusses the subtypes of alcohol dependence, and the nature of AUDs, in the context of DSM revisions.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Engaging Patients and Caregivers About Digital Therapeutics
FCS and SHTG: Are We Meeting the Need?
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Collaborative Insights to Solve the Puzzle of Bladder Cancer
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?